TOPICS: COVID-19Country stories

 

A campaign that saw 18 million children under the age of five vaccinated in the Democratic Republic of the Congo (DRC) is part of the effort which successfully brought the world’s largest measles outbreak to an end.

DRC Health Minister, Eteni Longondo said on Tuesday that the 25-month-long outbreak, which has claimed the lives of more than 7,000 children, was over. The news marked a double cause for celebration as it was made during the World Health Organization (WHO) Africa Region’s press conference where another African milestone was also announced: that the region had been officially certified as free from wild polio.

The end of the measles outbreak was the result of a shared effort by the DRC Ministry of Health, WHO, Gavi, the Vaccine Alliance and other partner aid agencies who joined forces in 2019 to respond to the outbreak by vaccinating more than 18 million children under the age of five against the deadly disease. This vaccination outreach project had a significant impact on reducing the incidence of new suspected measles cases.

While this campaign was vital in ending the outbreak, other vaccination outreach activities were held in 2020 with COVID-19 infection control measures in place, also played an important part. Over 1 million children between the ages of 6 to 59 months and more than 700,000 children who do not have regular access to vaccines were vaccinated against measles, thanks to these outreach activities supported by UNICEF and others.

By mid-July 2020, the number of new cases had fallen to 400 per week, compared to more than 9,000 during the peak of the outbreak in October-November 2019.

The news of the end of the measles outbreak is supported by both WHO and UNICEF teams in DRC. It marks a significant achievement particularly in light of the fact that the country has also been grappling with an ongoing response to the COVID-19 pandemic, a cholera outbreak and a major Ebola outbreak in the North Kivu region, which has recently been brought to an end.

The end of this measles outbreak shows the tremendous determination and skill of the DRC health ministry and frontline health workers.

 

Despite this positive news, the COVID-19 pandemic is continuing to present new challenges to recent efforts to improve immunisation coverage in DRC. Health workers are often without access to adequate personal protective equipment (PPE) to conduct immunisation sessions, parents are reluctant to bring their children to vaccination sessions due to fear of transmission, and the spread of misinformation and rumours about the virus, all pose barriers to the continuation of routine immunisation.

Data from the DRC’s Expanded Programme on Immunization (EPI) application identified a decrease of 10% in average attendance of children at immunisation sessions in the capital, Kinshasa, in April 2020, compared to the previous month. To limit the impact of COVID-19 on routine immunisation demand and service delivery, the DRC Ministry of Health has put some key measures in place. These include an issuance of directives at the end of March to maintain routine immunisation services in the COVID-19 context and a communications campaign using television and social media to combat the spread of false rumours.

In this context, while national funding for vaccines has long been a key challenge towards improving coverage, DRC has been recognised for its recent efforts to boost national investments in vaccines. In April–May 2020, the DRC government disbursed US$ 16.4 million for the purchase of vaccines – double what was spent in 2019 – in accordance with the commitment made at the National Forum on Immunization and Polio Eradication in July 2019. Though DRC has and continues to face significant challenges in the fight against vaccine-preventable diseases, including the ongoing Ebola outbreak in Equateur province, the Ministry of Health and the dedicated health workers on the ground have shown their commitment time and time again to protecting the Congolese people against infectious diseases.

Read the full 25 August situation report, here.

Related content

Gavi’s long-term approach to developing healthy markets for critical vaccines has led to greater stability and security, providing countries with the confidence that supplies will be available to meet their demand.

In 2019, a higher share of Gavi-supported countries than ever before met their co-financing obligations on time, thanks to strong political commitment.

In 2019, countries delivered more than 230 million routine vaccinations, a record number, supported by unprecedented levels of health system funding from Gavi to support immunisation and protect the most vulnerable children. Here is what Gavi did…

The goal of our market shaping work is to help ensure vaccine markets work better for lower-income countries. We want the maximum number of people to receive the life-saving and health-protecting benefits of immunisation.

After transitioning out of Gavi support in 2017, the Republic of Moldova is mobilising champions and advocates to strengthen vaccine confidence – which is crucial to the success and sustainability of immunisation programmes.

Typhoid fever is increasingly resistant to the main antibiotics used to treat it. Gavi is supporting a new vaccine to help control this deadly disease – and fight antimicrobial resistance.

September 2020 marks the 75th anniversary of the United Nations General Assembly (UNGA). This year, the focus of the high-level General Debate is the importance of effective multilateralism.

Snapshots from DRC, India and Zambia illustrate country ownership and progress in the fights against Ebola, polio and HPV.

Supporting health systems is essential for Gavi’s work to improve immunisation coverage and equity.

If a COVID-19 vaccine is to reach the global public sometime next year, it will be the result of one of the fastest developments and rollouts of a vaccine against a new disease ever. In contrast, the RTS,S malaria vaccine, which is currently…

Ethiopia has overtaken Nigeria to become the Gavi-eligible African country most affected by COVID-19. Over the past week, the number of confirmed cases in Ethiopia has grown exponentially. Despite the pandemic, immunisation activities – both…

Scientists around the world are working at an unprecedented pace to test different types of vaccines that could help to stop the spread of COVID-19.

3 September 2020

COVAX explained

To end this global health crisis we don’t just need COVID-19 vaccines, we also need to ensure that everyone in the world has access to them.

Before the pandemic began, the Democratic Republic of the Congo (DRC) was already facing a severe measles outbreak which started at the end of 2018. Despite huge challenges caused by COVID-19 and other diseases, the largest measles outbreak in…

The funding will support the Gavi COVAX Advance Market Commitment (AMC), which aims to secure doses of COVID-19 vaccines for 92 low- and middle-income countries and economies at the same time as wealthier nations

New landmark collaboration between the Serum Institute of India (SII), Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation to accelerate manufacturing and delivery of up to 100 million doses of future safe and effective COVID-…

Despite disruption to routine immunisation in Gavi-eligible countries due to COVID-19, collaborative efforts between Alliance partners and governments have made it possible to partially resume immunisation sessions in countries such as Pakistan…

Briefings led by Gavi, CEPI and WHO over the past two weeks saw participation from at least 136 countries interested in joining a COVAX Facility aimed at guaranteeing equitable access to eventual COVID-19 vaccines.

A spotlight on Ethiopia, India, the Solomon Islands and Zambia

Governments have had to act fast to not only protect their people against COVID-19 but also to ensure protective measures like vaccination against other infectious diseases…

Across Gavi-eligible countries, we have seen a consistent increase in cases since March 2020. Within the month of June alone, the number of cases has more than doubled, with 70 out of 73 Gavi-eligible countries reporting over 1 million confirmed…

Gavi Board shows support for continued work on COVAX Facility: a global, coordinated mechanism designed to ensure rapid and equitable access to safe and efficacious COVID-19 vaccines to as broad a global population as possible

There has been a huge variation in how countries have responded to COVID-19. Whilst some have imposed strict lockdown measures, others have avoided tight restrictions. But what works best?

Seventy (of 73) Gavi-eligible countries have reported 824,259 confirmed cases and 20,641 deaths. The number of cases is increasing at an average rate of 4% from the previous day.

Even mild symptoms from the new coronavirus can last for weeks, or disappear only to rebound with renewed intensity, so what long-term effects does the disease have on our health?

As the devastating consequences of the pandemic unfold across the world, COVID-19 is making long-lasting changes in global health

So far relatively few people in Africa have been infected by the novel coronavirus, with around 215,000 cases and 5,800 deaths in a population of 1.2 billion in the continent. But with lockdowns lifting, will cases soar?

New supply agreement between UNICEF and Serum Institute of India (SII) makes pneumococcal conjugate vaccine (PCV) available at US$2.00 per dose, a 43% reduction from the Gavi price at the start of the AMC

Despite the devastating economic impact this pandemic has had on businesses across the world, many are doing their part to bring this crisis to an end.

Ideally, humanity would end COVID-19 by eradicating it so there are no new cases globally even in the absence of preventive measures. However, experience with other disease eradication programmes indicates that this will be very challenging, and…

Seventy (out of 73) Gavi-eligible countries have reported 475,401 confirmed cases and 12,464 deaths. Though this number still accounts for a small proportion, about 7%, of global COVID-19 cases, this share is expected to increase given the…

The Global Vaccine Summit, hosted by the UK, raises US$ 8.8 billion from 32 donor governments and 12 foundations, corporations and organisations to immunise 300m children and support the global fight against COVID-19.

Gavi Advance Market Commitment for COVID-19 Vaccines (Gavi Covax AMC) launched at Global Vaccine Summit 2020 draws strong support, early commitments from global leaders.

In the absence of a vaccine or treatment against the new coronavirus, measures to control its spread rely on avoiding contact with people who we are not sharing a house with. This study shows the varying effects of such preventive measures.

Seventy (out of 73) Gavi-eligible countries have reported 257,996 confirmed cases and 7,547 deaths. These 70 countries account for a small proportion, about 5%, of global COVID-19 cases and 2% of global deaths.

Agencies call for joint effort to safely deliver routine immunization and proceed with vaccination campaigns against deadly vaccine-preventable diseases.

Sixty-nine (out of 73) Gavi-eligible countries have reported 123,129 confirmed cases and 3,941 deaths, five more countries than the 64 announced last week. These countries account for about 3% of global COVID-19 cases and deaths.

How we can ensure that once a COVID-19 vaccine is available, it is accessible to everyone that needs it.

The COVID-19 pandemic has placed a heavy burden on global economies, health care systems and other core sectors. Gavi is helping countries reallocate their health system strengthening grants to provide fast and flexible funding for vital…

As part of Gavi’s work supporting lower-income countries’ response to COVID-19, the Alliance is providing US$ 40 million to UNICEF to secure supplies of personal protective equipment (PPE) and diagnostics for 58 countries.

The COVID-19 pandemic has placed a heavy burden on global economies, healthcare systems and other core sectors. Gavi is helping countries reallocate their health system strengthening grants to provide fast and flexible funding for vital resources…

Goal of new global collaboration is to make COVID-19 diagnostics, therapeutics and vaccines available to everybody that needs them as quickly as possible.

How the 2009 H1N1 influenza pandemic can help us be better prepared for distributing and administering potential COVID-19 vaccines.

At least 13.5 million people to miss out on vaccinations due to postponement of campaigns and interruptions in routine vaccinations, with millions more likely to follow.

Imperial model of the spread of COVID-19 implies a suppression strategy could be most effective.

Gavi, the Vaccine Alliance applauds the commitment of the G20 Leaders chaired by Saudi Arabia “to provide immediate resources to the WHO’s…

With the COVID-19 pandemic already affecting 47 Gavi-supported countries, Gavi, the Vaccine Alliance has already taken new steps to help strengthen the preparedness of health systems in lower-income countries with the full support of its Board.…

Subscribe to our newsletter